Does Oscar Health Cover GLP-1? Marketplace Plan Rules Explained

Why Oscar's GLP-1 answer is usually "no"

Oscar Health built its business on ACA marketplace and small-group plans — the plan types where weight-loss drug coverage is weakest by design. Anti-obesity medications are not an ACA essential health benefit, so marketplace insurers can exclude them entirely. With GLP-1 costs exploding, most marketplace plans — Oscar included — have taken the exclusion route. Employer-sponsored plans can opt into coverage; marketplace plans mostly haven't.

The diabetes exception

Where coverage does exist, it follows the standard split: Ozempic and Mounjaro for type 2 diabetes get covered far more often than Wegovy or Zepbound for weight loss. If you have a diabetes diagnosis, expect prior authorization and usually a metformin-first requirement — but coverage is real. Without diabetes, the formulary exclusion usually applies regardless of documentation quality. See ACA marketplace GLP-1 guide, Ambetter coverage, and BCBS coverage.

How to check YOUR specific plan

• Log into your Oscar member portal — formulary/drug list is searchable.
• Call the number on your card — ask specifically: "Is Wegovy (or Zepbound) on my formulary for weight loss, and what is the PA criteria?"
• Check for the word "exclusion" — a formulary exclusion can't be appealed; only PA denials can.

The cash-pay fallback math

Frequently asked questions

Does Oscar Health cover Wegovy or Zepbound?

Rarely. Oscar sells mostly individual/ACA-marketplace and small-group plans — and most ACA marketplace plans exclude weight-loss medications entirely (they're not an essential health benefit). Some Oscar plans cover them with prior auth; check your plan's formulary or call the number on your card.

Does Oscar cover Ozempic for diabetes?

More likely — diabetes-indicated GLP-1s (Ozempic, Mounjaro) are covered on many Oscar formularies with prior authorization and usually metformin step therapy. The same drug prescribed for weight loss without a diabetes diagnosis typically gets denied.

Why don't marketplace plans cover weight-loss drugs?

Anti-obesity medications are not an essential health benefit under the ACA — marketplace insurers can exclude them without violating federal rules. Rising GLP-1 costs have pushed most marketplace plans to explicitly exclude weight-loss indications rather than absorb the expense.

What if Oscar denies my GLP-1?

If the denial is a formulary exclusion (most common on marketplace plans), appeals rarely succeed — you can't appeal an exclusion, only a coverage decision. The practical fallback is cash-pay: LillyDirect for Zepbound ($299-449), NovoCare for Wegovy, or compounded semaglutide via telehealth at $119-299/month.

Does Oscar cover compounded semaglutide?

No — no insurer covers compounded GLP-1s anywhere. They're cash-pay products, which is exactly why telehealth programs bundle them at $119-299/month for patients without coverage.

Bottom line

Oscar's marketplace structure means weight-loss GLP-1 coverage is the exception, not the rule — and exclusions aren't appealable. If your plan covers diabetes GLP-1s, use that path; if weight loss is the goal and the plan excludes it, $119/month compounded semaglutide is the uninsured reality.